WebMD Announces Exploration Of Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
WebMD (WBMD) PT Raised to $55 at Mizuho Securities Following 4Q Results, Strategic Options
February 17, 2017 5:45 AM ESTMizuho analyst Neil Doshi reiterates Neutral rating and raises price target on WebMd Health Corp. (NASDAQ: WBMD) to $55 (from $52), noting a disappointing outlook and back-end loaded growth, as the company reported 2016 fourth quarter results in-line with estimates, while exploring strategic alternatives.
Doshi... More
WebMD Health (WBMD) Tops Q4 EPS by 7c; Guides Q1, FY17 Revs Below Views
February 16, 2017 4:04 PM ESTWebMD Health (NASDAQ: WBMD) reported Q4 EPS of $0.73, $0.07 better than the analyst estimate of $0.66. Revenue for the quarter came in at $207.5 million versus the consensus estimate of $206.99 million.
GUIDANCE:
WebMD Health sees Q1 revs of $151 million to $154 million versus the... More



